NCT01920308View on ClinicalTrials.gov

A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

July 31, 2015

Conditions
Peripheral Artery Disease
Interventions
DEVICE

5 mm Bard LifeStent Vascular Stent

The LifeStent® Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240 mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 - 6.5 mm.

Trial Locations (1)

79187

University Heart Centre Bad Krozingen, Bad Krozingen

Sponsors

Lead Sponsor

C. R. Bard
All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT01920308 - A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY) | Biotech Hunter | Biotech Hunter